Impax Laboratories Up On FDA Approval (IPXL)
Impax Laboratories, Inc. (NASDAQ: IPXL) is up around 1% in early Wednesday trading after the company received final FDA approval today for generic Doryx 75 and 100mg tablets.
At last check, shares of Impax were up 23 cents to $20.73, a gain of 1.1%.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.